Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cisco
CSCO
$480B
| $824M | 1.02% |
20,969,492
-9,397,997
| -31% | -$412M |
|
27
iShares MBS ETF
MBB
$39.1B
| $781M | 0.97% |
7,071,609
+258,478
| +4% | +$28.1M |
|
28
Sanofi
SNY
$102B
| $772M | 0.96% |
17,662,027
+114,682
| +0.7% | +$5.49M |
|
29
TotalEnergies
TTE
$189B
| $748M | 0.93% |
20,095,125
+291,537
| +1% | +$13.1M |
|
30
AstraZeneca
AZN
$241B
| $739M | 0.92% |
8,278,287
+92,933
| +1% | +$8.75M |
|
31
Novartis
NVS
$291B
| $704M | 0.87% |
8,534,868
+113,098
| +1% | +$10.1M |
|
32
Merck
MRK
$316B
| $685M | 0.85% |
9,335,072
+18,316
| +0.2% | +$1.44M |
|
33
PayPal
PYPL
$50.1B
| $671M | 0.83% |
7,003,347
+2,775,699
| +66% | +$306M |
|
34
Caterpillar
CAT
$404B
| $651M | 0.81% |
5,609,147
+62,036
| +1% | +$7.92M |
|
|
35
Meta Platforms (Facebook)
META
$1.5T
| $643M | 0.8% |
3,852,395
+3,542,165
| +1,142% | +$693M |
|
36
Oracle
ORCL
$420B
| $638M | 0.79% |
13,209,055
-2,754,898
| -17% | -$142M |
|
|
FIYY
37
DELISTED
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
| $628M | 0.78% |
9,680,548
-226,485
| -2% | -$23.3M |
|
38
Eli Lilly
LLY
$995B
| $601M | 0.75% |
4,334,447
-77,563
| -2% | -$10.7M |
|
39
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.6B
| $596M | 0.74% |
19,699,477
-161,703
| -0.8% | -$4.94M |
|
40
GSK
GSK
$103B
| $589M | 0.73% |
12,431,972
+101,603
| +0.8% | +$5.42M |
|
|
SI
41
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $549M | 0.68% |
12,909,979
+61,159
| +0.5% | +$2.6M |
|
42
JPMorgan Chase
JPM
$950B
| $544M | 0.67% |
6,039,705
+80,640
| +1% | +$9.8M |
|
43
Union Pacific
UNP
$176B
| $528M | 0.66% |
3,746,433
+1,897,913
| +103% | +$314M |
|
|
RDS.A
44
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $520M | 0.64% |
14,896,649
+371,868
| +3% | +$17.4M |
|
45
Rio Tinto
RIO
$161B
| $508M | 0.63% |
11,140,243
+123,742
| +1% | +$6.35M |
|
|
46
Nike
NKE
$61.6B
| $488M | 0.6% |
5,892,758
+5,862,137
| +19,144% | +$545M |
|
47
RTX Corp
RTX
$294B
| $454M | 0.56% |
7,645,397
+69,890
| +0.9% | +$5.91M |
|
|
48
Walt Disney
DIS
$170B
| $435M | 0.54% |
4,504,570
+4,423,621
| +5,465% | +$559M |
|
49
Chevron
CVX
$379B
| $369M | 0.46% |
5,096,800
-83,143
| -2% | -$8.22M |
|
50
Intuitive Surgical
ISRG
$130B
| $350M | 0.43% |
2,120,793
+1,920,003
| +956% | +$352M |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.